Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil and Prednisolone Versus Prednisolone Alone in Fibrotic Hypersensitivity Pneumonitis
NCT05626387Phase 4Active, not recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Nov 2022
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in hypersensitivity pneumonitis (HP), sponsored by Post Graduate Institute of Medical Education and Research. Started Nov 2022; status: active, not recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
hypersensitivity pneumonitis (HP)
Beyond the preview
Go deeper on NCT05626387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05626387.